Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 1.000 | |
| 4uxq | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.624 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.596 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.588 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.577 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.546 | |
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.545 | |
| 3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.542 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.537 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.536 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.533 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.526 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.525 | |
| 2a4n | COA | Aac(6')-Ii protein | / | 0.520 | |
| 2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.511 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.510 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.510 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.508 | |
| 1fgi | SU1 | Fibroblast growth factor receptor 1 | / | 0.502 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.501 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.501 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.501 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.499 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.499 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.499 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.497 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.496 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.495 | |
| 3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.494 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.493 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.493 | |
| 3zei | AWH | O-acetylserine sulfhydrylase | / | 0.491 | |
| 4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.491 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.490 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.490 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.489 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.487 | |
| 4agc | AXI | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.487 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
| 1dis | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.485 | |
| 4jlk | 1NO | Deoxycytidine kinase | 2.7.1.74 | 0.485 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.485 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.484 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.484 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.483 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
| 5dc5 | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.482 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.481 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.481 | |
| 3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.481 | |
| 3dko | IHZ | Ephrin type-A receptor 7 | 2.7.10.1 | 0.481 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.481 | |
| 1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.480 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.480 | |
| 3g0f | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.480 | |
| 4kuh | CAA | 3-hydroxybutyryl-CoA dehydrogenase | / | 0.480 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.479 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.478 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.477 | |
| 3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.477 | |
| 3aba | FLI | Cytochrome P450 | / | 0.476 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.476 | |
| 4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.476 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.476 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.475 | |
| 2osc | MUH | Angiopoietin-1 receptor | 2.7.10.1 | 0.475 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.474 | |
| 2wes | FAD | Tryptophan 5-halogenase | / | 0.474 | |
| 2yac | 937 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.474 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.474 | |
| 4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.474 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.473 | |
| 3nax | MP7 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.473 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.473 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.472 | |
| 3f82 | 353 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.472 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.472 | |
| 4elb | 34R | Dihydrofolate reductase | / | 0.472 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.472 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.472 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.472 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.471 | |
| 3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.471 | |
| 2d29 | FAD | Acyl-CoA dehydrogenase | / | 0.470 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.470 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
| 4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.470 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.469 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
| 3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.469 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.469 | |
| 4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.469 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.469 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.469 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.469 | |
| 2dr3 | ADP | UPF0273 protein PH0284 | / | 0.468 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.468 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.468 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.468 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.468 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.468 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.467 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.467 | |
| 4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.467 | |
| 4h3g | 10Q | Beta-secretase 1 | 3.4.23.46 | 0.467 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.467 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.467 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.467 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
| 3dh7 | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.466 | |
| 3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.466 | |
| 3zs5 | SB2 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.466 | |
| 1n71 | COA | Aac(6')-Ii protein | / | 0.465 | |
| 2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.465 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.464 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
| 2tsc | CB3 | Thymidylate synthase | / | 0.464 | |
| 3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.464 | |
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.464 | |
| 4b1f | KRH | Glutamate racemase | / | 0.464 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.464 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.464 | |
| 2cle | F6F | Tryptophan synthase alpha chain | / | 0.463 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.463 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.462 | |
| 2z3u | CRR | Cytochrome P450 | / | 0.462 | |
| 3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.462 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.462 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.462 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.461 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.461 | |
| 4x5j | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
| 1b87 | ACO | Aac(6')-Ii protein | / | 0.460 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.460 | |
| 2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.460 | |
| 3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.460 | |
| 3zsg | T75 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.459 | |
| 3cr7 | PPS | Adenylyl-sulfate kinase | 2.7.1.25 | 0.459 | |
| 3htj | ET | EbrA repressor | / | 0.459 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.459 | |
| 4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.459 | |
| 4elf | 35I | Dihydrofolate reductase | / | 0.459 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.459 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.459 | |
| 4kw5 | 1W6 | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.459 | |
| 4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.459 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.459 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 2i9p | NAD | 3-hydroxyisobutyrate dehydrogenase, mitochondrial | 1.1.1.31 | 0.458 | |
| 2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.458 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.458 | |
| 4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.458 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.458 | |
| 4hvs | 647 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.458 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.458 | |
| 1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
| 1tdr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
| 2h42 | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.457 | |
| 3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.457 | |
| 3owu | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.457 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.457 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.457 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.456 | |
| 1jol | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 1jom | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 1kce | CB3 | Thymidylate synthase | / | 0.456 | |
| 1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.456 | |
| 3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
| 4nie | NBH | Nuclear receptor ROR-gamma | / | 0.456 | |
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 4iae | 1DX | Alr2278 protein | / | 0.455 | |
| 4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.455 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.455 | |
| 1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.454 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2jbs | FMN | p-hydroxyphenylacetate 3-hydroxylase, oxygenase component | / | 0.454 | |
| 2vd0 | D27 | Hematopoietic prostaglandin D synthase | / | 0.454 | |
| 2xlr | FAD | Putative flavin-containing monooxygenase | / | 0.454 | |
| 3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.454 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.454 | |
| 3v94 | WYQ | Phosphodiesterase | / | 0.454 | |
| 4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.454 | |
| 4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.454 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.454 | |
| 1w83 | L11 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 2b04 | CHO | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.453 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
| 2uag | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.453 | |
| 2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.453 | |
| 2xnn | 430 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.453 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
| 1zdw | FLV | Prenyltransferase | / | 0.452 | |
| 2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.452 | |
| 3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.452 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 3zcn | ATP | Adenosine monophosphate-protein transferase SoFic | 2.7.7.n1 | 0.452 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.452 | |
| 4y6g | F6F | Tryptophan synthase alpha chain | / | 0.452 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.451 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2xk4 | OL2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.451 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.451 | |
| 3hu2 | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.451 | |
| 3oqk | S52 | Renin | 3.4.23.15 | 0.451 | |
| 3ozd | 4CT | S-methyl-5'-thioadenosine phosphorylase | / | 0.451 | |
| 3pqb | VGP | Putative oxidoreductase | / | 0.451 | |
| 3zkp | ERB | Erythromycin C-12 hydroxylase | 1.14.13.154 | 0.451 | |
| 4cax | 646 | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.451 | |
| 4g1n | NZT | Pyruvate kinase PKM | 2.7.1.40 | 0.451 | |
| 4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.451 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.451 | |
| 1ju6 | LYA | Thymidylate synthase | 2.1.1.45 | 0.450 | |
| 2fr0 | NDP | 6-deoxyerythronolide-B synthase EryA1, modules 1 and 2 | / | 0.450 | |
| 3ggs | 2FD | Purine nucleoside phosphorylase | 2.4.2.1 | 0.450 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.450 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.450 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.450 | |
| 4htx | 19F | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.450 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.450 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
| 1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
| 1rf7 | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.449 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.449 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.449 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.449 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.449 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 4b6l | 9ZP | Serine/threonine-protein kinase PLK3 | 2.7.11.21 | 0.449 | |
| 4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.449 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.449 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.449 | |
| 4kln | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.449 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.449 | |
| 4mlp | 2CX | Cryptochrome-2 | / | 0.449 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.449 | |
| 1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.448 | |
| 2wsa | 646 | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
| 3arv | SAU | Chitinase A | / | 0.448 | |
| 3gcp | SB2 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.448 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.448 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
| 4ag8 | AXI | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
| 4at3 | LTI | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.448 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.448 | |
| 5dp2 | NAP | CurF | / | 0.448 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.448 | |
| 1juj | LYA | Thymidylate synthase | 2.1.1.45 | 0.447 | |
| 1olm | VTQ | SEC14-like protein 2 | / | 0.447 | |
| 1syn | F89 | Thymidylate synthase | / | 0.447 | |
| 2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.447 | |
| 2gvc | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.447 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2hrc | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.447 | |
| 2xk8 | 5R1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.447 | |
| 2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.447 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.447 | |
| 3vtb | TKA | Vitamin D3 receptor | / | 0.447 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.447 | |
| 4elh | 53I | Dihydrofolate reductase | / | 0.447 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
| 4h97 | 53S | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 1kij | NOV | DNA gyrase subunit B | / | 0.446 | |
| 1re7 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.446 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.446 | |
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.446 | |
| 2wpx | ACO | Orf14 | / | 0.446 | |
| 2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.446 | |
| 3h1v | TK1 | Glucokinase | 2.7.1.2 | 0.446 | |
| 3lu8 | IQX | Serum albumin | / | 0.446 | |
| 3new | 3NE | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.446 | |
| 3p6p | A6B | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.446 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
| 4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.446 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 4la0 | 198 | Serum albumin | / | 0.446 | |
| 1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 1t4c | COA | Formyl-CoA:oxalate CoA-transferase | / | 0.445 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
| 2pnj | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
| 2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.445 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 3p2o | NAD | Bifunctional protein FolD | / | 0.445 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
| 4hkf | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.445 | |
| 4o76 | 1M3 | Bromodomain-containing protein 4 | / | 0.445 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.445 | |
| 1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.444 | |
| 1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
| 1p91 | SAM | 23S rRNA (guanine(745)-N(1))-methyltransferase | / | 0.444 | |
| 1qzf | CB3 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.444 | |
| 2igo | FAD | Pyranose 2-oxidase | / | 0.444 | |
| 2jfg | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.444 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 2ol4 | JPN | Enoyl-ACP reductase | / | 0.444 | |
| 2pam | TYD | TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase | 5.3.2.3 | 0.444 | |
| 3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3k1w | BFX | Renin | 3.4.23.15 | 0.444 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 4h1e | 10J | Beta-secretase 1 | 3.4.23.46 | 0.444 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 1kuv | CA5 | Serotonin N-acetyltransferase | / | 0.443 | |
| 1xmm | M7G | m7GpppX diphosphatase | 3.6.1.59 | 0.443 | |
| 1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.443 | |
| 2a1t | FAD | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.7 | 0.443 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
| 3g0e | B49 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.443 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 4ge7 | 0K5 | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.443 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.443 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
| 4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.443 | |
| 4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.443 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 1uye | PU9 | Heat shock protein HSP 90-alpha | / | 0.442 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 2dhf | DZF | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.442 | |
| 2j9l | ATP | H(+)/Cl(-) exchange transporter 5 | / | 0.442 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
| 3ey4 | 352 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.442 | |
| 3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.442 | |
| 3zux | TCH | Transporter | / | 0.442 | |
| 4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.442 | |
| 4b4v | L34 | Bifunctional protein FolD | / | 0.442 | |
| 4ele | 31I | Dihydrofolate reductase | / | 0.442 | |
| 4zir | ANP | Energy-coupling factor transporter ATP-binding protein EcfA2 | 3.6.3 | 0.442 | |
| 4zir | ANP | Energy-coupling factor transporter ATP-binding protein EcfA1 | / | 0.442 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 1ppj | SMA | Cytochrome b | / | 0.441 | |
| 1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.441 | |
| 1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.441 | |
| 2ykc | YKC | Heat shock protein HSP 90-alpha | / | 0.441 | |
| 2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
| 3bfa | 9OD | Odorant binding protein ASP1 | / | 0.441 | |
| 3f0a | ACO | Spermidine N(1)-acetyltransferase | / | 0.441 | |
| 3p9t | TCL | Repressor | / | 0.441 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.441 | |
| 3zia | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.441 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.441 | |
| 4eh9 | IRG | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 5c1m | CLR | Mu-type opioid receptor | / | 0.441 | |
| 1aiq | CB3 | Thymidylate synthase | / | 0.440 | |
| 1dna | CB3 | Thymidylate synthase | / | 0.440 | |
| 1rc4 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
| 1xdk | REA | Retinoic acid receptor beta | / | 0.440 | |
| 2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.440 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.440 | |
| 3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 3gnc | QQQ | Glutaryl-CoA dehydrogenase | / | 0.440 | |
| 3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 4c77 | N01 | Phenylacetone monooxygenase | 1.14.13.92 | 0.440 | |
| 4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.440 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4tqq | UQ1 | Reaction center protein L chain | / | 0.440 |